Michael Holder - 05 Jun 2024 Form 4 Insider Report for Cytek Biosciences, Inc. (CTKB)

Role
Director
Signature
/s/ Valerie Barnett, Attorney-in-Fact
Issuer symbol
CTKB
Transactions as of
05 Jun 2024
Net transactions value
$0
Form type
4
Filing time
07 Jun 2024, 19:09:10 UTC
Previous filing
06 Jul 2022
Next filing
21 Aug 2024
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction CTKB Restricted Stock Units Award $0 +26,178 $0.000000 26,178 05 Jun 2024 Common Stock 26,178 Direct F1, F2
transaction CTKB Stock Option (right to buy) Award $0 +37,878 $0.000000 37,878 05 Jun 2024 Common Stock 37,878 $5.73 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.
F2 2/36 of the total shares subject to the RSU Award shall vest on August 18, 2024; 3/36 of the total shares subject to the RSU Award shall vest on November 18, 2024 and each November 18 thereafter; 4/36 of the total shares underlying the RSU Award shall vest on March 10, 2025 and each March 10 thereafter; 2/36 of the total shares underlying the RSU Award vesting shall vest on May 18, 2025 and each May 18 thereafter; and 3/36 of the total shares underlying the RSU Award shall vest on August 18, 2025 and each August 18 thereafter, until fully vested.
F3 1/36 of the total shares subject to the option shall vest monthly over 3 years following the grant date of June 5, 2024.